ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
A Combinatorial Approach to Target the Tumor-Initiating and Transit Amplifying Cellular Subpopulations in Diffuse Intrinsic Pontine Glioma (DIPG) | Stanford University / Michelle Monje, MD, PhD | 'A' Award Grants | 2011 | California |
Blockade of p53 and Aurora A in Therapy Resistant Neuroblastoma | University of California San Francisco / William Clay Gustafson, MD, PhD | 'A' Award Grants | 2011 | California |
Preliminary Content Validation Steps for the Pediatric Oncology Patient Self-Report CTCAE | Children’s National Medical Center / Pamela Hinds | Nurse Researcher Grants | 2011 | District of Columbia |
Development of a Connectedness with Healthcare Providers Scale for Adolescents and Young Adults with Cancer | Indiana University / Celeste Phillips-Salimi | Nurse Researcher Grants | 2011 | Indiana |
COPE in Parents of Children Diagnosed with Cancer | University of Arizona / Gloanna Peek | Nurse Researcher Grants | 2011 | Arizona |
BH3 Profiling to define therapy resistance classes in neuroblastoma | Children’s Hospital of Philadelphia / Michael Hogarty, MD | Innovation Grants | 2011 | Pennsylvania |
Modeling Anaplastic Medulloblastoma using Cerebellar Stem Cells | Sanford-Burnham Medical Research Institute / Robert Wechsler-Reya, PhD | Innovation Grants | 2011 | California |
Clinical Development of RNA Nanoparticle Vaccines Targeting Recurrent Pediatric Brain Cancers | Duke University / Duane Mitchell, MD, PhD | Innovation Grants | 2011 | North Carolina |
Strategies for Epigenetically Reprogramming Neuroblastoma Cancer Stem Cells | Baylor College of Medicine / Jason Shohet, MD, PhD | Innovation Grants | 2011 | Texas |
Predicting Outcome and Ameliorating Toxicities of the Immunotherapy of Neuroblastoma | University of California, San Diego / Alice Yu, MD, PhD | Innovation Grants | 2011 | California |
Studying the clonal dynamics and evolution of leukemia using molecular barcodes | Lucile Packard Children’s Hospital at Stanford University School of Medicine / Matthew Porteus, MD, PhD | Innovation Grants | 2011 | California |
Targeting inhibitory phosphatase signaling in high-risk childhood ALL | University of California San Francisco / Markus Muschen, MD, PhD | Innovation Grants | 2011 | California |
The role of primary cilia in rhabdomyosarcoma | New York University School of Medicine / Brian Dynlacht, PhD | Innovation Grants | 2011 | New York |
Blockade of MYCN in neuroblastoma | University of California San Francisco / William Weiss, MD/PhD | Innovation Grants | 2011 | California |
Racial and Ethnic Disparities in Survival of Children with Neuroblastoma | University of Chicago / Susan Cohn, MD | Innovation Grants | 2011 | Illinois |
Investigating the Role of Lin-28 in Germ Cell Tumorigenesis | Boston Children’s Hospital / George Daley, MD/PhD | Innovation Grants | 2011 | Massachusetts |
In vivo Analysis of Neuroblastoma Pathogenesis using Transgenic Zebrafish | Dana-Farber Cancer Institute / Alfred Tom Look, MD | Innovation Grants | 2011 | Massachusetts |
The Role of Mxi1 in the Modulation N-Myc Function in Neuroblastoma | Duke University / Michael Armstrong | Young Investigator Grants | 2011 | North Carolina |
Using zebrafish to model the molecular origins of pediatric myeloid malignancies and acute myeloid leukemia | Dana-Farber Cancer Institute / Evisa Gjini | Young Investigator Grants | 2011 | Massachusetts |
Targeting HMGA1 in Childhood ALL | The Johns Hopkins University School of Medicine / Amy M. Belton, PhD | Young Investigator Grants | 2011 | Maryland |
Mechanisms of Oncogenic Transformation by TLX1/HOX11 | University of Michigan / Mark Chiang | Young Investigator Grants | 2011 | Michigan |
Altering master genetic regulators SNF5/INI1 and LIN28A to model and treat atypical teratoid/rhabdoid tumors | The Johns Hopkins University School of Medicine / Eric Raabe | Young Investigator Grants | 2011 | Maryland |
Validation of microRNAs as valid targets in a pediatric sarcoma | University of Texas Southwestern Medical Center / Mark Hatley | Young Investigator Grants | 2011 | Texas |
Identification of Alveolar Rhabdomyosarcoma "Achilles' Heel" | National Cancer Institute / Fernanda Arnaldez | Young Investigator Grants | 2011 | Maryland |
Targeting the Mechanism of Differentiation Arrest in a Novel Model of Acute Leukemia | Massachusetts General Hospital / David Sykes | Young Investigator Grants | 2011 | Massachusetts |
Targeting polycomb-mediated epigenetic silencing in T cell acute lymphoblastic leukemia | Vanderbilt University Medical Center / Emmanuel Volanakis | Young Investigator Grants | 2011 | Tennessee |
Telomeres and Telomerase in Pediatric Acute Myeloid Leukemia | Baylor College of Medicine / Maria Gramatges | Young Investigator Grants | 2011 | Texas |
Investigation of Genetic and Molecular Mechanisms of Second Malignant Neoplasms in a Mouse Model | University of California San Francisco / Jean Nakamura | Young Investigator Grants | 2011 | California |
Engineering A Graft Versus Leukemia Effect into Cord Blood Transplant for Acute Lymphoblastic Leukemia | Fred Hutchinson Cancer Research Center / Rebecca Gardner | Young Investigator Grants | 2011 | Washington |
SickKids MIBG and Phase I Leukemia Programs | Hospital for Sick Children / James Whitlock, MD | Phase I/II Infrastructure Grants | 2011 | Ontario |
Children's Hospital of Pittsburgh of UPMC Phase 1-2 Infrastructure Support Grant | University of Pittsburgh / A. Kim Ritchey | Phase I/II Infrastructure Grants | 2011 | Pennsylvania |
Phase I and II Clinical Research Program Infrastructure Award | University of Minnesota / Brenda Weigel, MD, MSc | Phase I/II Infrastructure Grants | 2011 | Minnesota |
Development of a Childhood Leukemia Translational Research Program | Dana-Farber Cancer Institute / Lewis Silverman | Phase I/II Infrastructure Grants | 2011 | Massachusetts |